ISCT and CMaT Report Success of Hands-On Laboratory Bootcamp for Cell Therapy Biomanufacturing; Fills Gap in Workforce Development
Workforce development is a buzz phrase spoken frequently during multistakeholder meetings and conferences, and rightfully so. As ISCT stated in a recent email, “The U.S. Food and Drug Administration (FDA) has approved 34 CGT products as of March 2024 and is expected to approve up to 20 CGT products annually by 2025.” With this explosive growth, laboratories will have substantial needs for a qualified workforce. An innovative solution provided via a collaboration between the International Society for Cell & Gene Therapy (ISCT) and the NSF Engineering Research Center for Cell Manufacturing Technologies (CMaT) at Georgia Tech is the Hands-On Laboratory Bootcamp for Cell Therapy Biomanufacturing.
ISCT recently published an article that outlined the resounding success of the first bootcamp, which took place this year from March 29 through April 3. The author, Raymond Lam, provided daily synopses over the course of the five-day bootcamp. This article provides detailed insight into how laboratories and their personnel can benefit from participating in a future bootcamp.
The second ISCT-CMaT Hands-on Laboratory Bootcamp for Cell Therapy Biomanufacturing Course will be from August 5–9, 2024. Register now to secure your spot!
